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1. Introduction 
GRDFs are those dosage forms which can remain in the gastric region for several hours and hence prolong the 
gastric residence time of drug. One of the most feasible approaches for achieving a prolonged and predictable drug delivery 
in the GI tract is to control the gastric residence time (GRT), by using gastro-retentive dosage forms (GRDFs). GRDFs 
offers several advantages over immediate release dosage form, including the minimization of fluctuations in drug 
concentration in plasma, and at the site of action over prolonged periods of time, resulting in optimized therapeutic 
efficiencies and reduce the side effect, reduction of total dose administered, (while providing similar therapeutic effect) and 
reduction of administration frequency, leading to improved patient compliances.[1-2] 
The drug of choice, Rabeprazole sodium, is an effective anti ulcer drug. Rabeprazole Sodium belongs to the class 
of anti-secretory compounds that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but suppress 
gastric acid secretion by inhibiting the gastric H+/K+ATPase at the secretary surface of the gastric parietal cell. 
Rabeprazole blocks the final step of gastric acid secretion, which is widely used for the management of peptic ulcer. It has a 
short biological half-life of 1-2 hours and bioavailability is 52%, which make it more suitable to be designed as a controlled 
release formulation. The main purpose of the present research was to develop mucoadhesive microspheres of Rabeprazole 
sodium for oral administration using biocompatible HPMC and carbopol polymers in order to increase its biological half 
life and to determine the influence of formulation and preparation variables on microparticles characteristics, such as drug 
incorporation and in vitro drug release [3-5]. 
              Conventional oral dosage forms such as tablets provide systemic circulation without offering any control over the 
drug delivery and also cause great fluctuation in the plasma drug levels. To avoid this drawback, mucoadhesive 
microspheres have been developed and have the advantage that they pass uniformly through the GIT to avoid the variation 
of gastric emptying and provide adjustable release, thereby reducing the intersubject variability in absorption and risk of 
local irritation.[6-7] 
The stability of Rabeprazole sodium is a function of pH; it is rapidly degrading acid media, and is more stable 
under alkaline conditions. Therefore exposure of Rabeprazole sodium to the acidic content of the stomach would lead to 
significant degradation of the drug and hence, reduced bioavailability. Therefore, the drug should be targeted in to intestine, 
to bypass the stomach. 
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2. Material and method 
Rabeprazole sodium obtained as a gift sample Hydroxy methyl cellulose, Span and liquid paraffin were purchased 
from Chemical Drug House, New Delhi. Other chemical used were of analytical grade.  
2.1 Preparation of Microspheres: 
Microspheres were prepared by emulsification solvent evaporation technique. Briefly, Rabeprazole sodium and 
polymers were mixed in 50ml distilled water. A different polymer ratio 1:1, 1:2, 1:3, and 1:4, used to prepare the different 
formulations. Polymeric aqueous solution was made in which the drug was dispersed and then the solution was added drop 
wise into 200 ml of light liquid paraffin containing 0.5% span‐80 as an emulsifying agent. The aqueous phase was 
emulsified in oily phase by stirring the system in a 500ml beaker, Constant stirring at 500 rpm was carried out using 
magnetic stirrer at 80ºC, stirring and heating were maintained for 4hrs, Until The aqueous phase was evaporated. The 
microspheres were washed 5 times with n‐hexane, filtered through whattman’s filter paper and dried in hot air oven at 50°C 
for 2 hours. 
Table 1:  Formulation of the microspheres prepared 
Formulation 
Code 
Rabeprazole 
sodium (mg) 
HPMC15cps 
+Carbopol934p(ratio) 
HPMC15000cps 
+Carbopol 934p(ratio) 
Liquid 
paraffin(ml) 
Span-80 
(0.5%) 
F1 100 1:1 - 200 0.5 
F2 100 1:2 - 200 0.5 
F3 100 1:3 - 200 0.5 
F4 100 1:4 - 200 0.5 
F5 100 - 1:1 200 0.5 
F6 100 - 1:2 200 0.5 
F7 100 - 1:3 200 0.5 
F8 100 - 1:4 200 0.5 
 
2.2 Evaluation of Mucoadhesive microspheres 
2.2.1 Percentage yield: 
The prepared microspheres were collected and weighed from different formulations. The measured weight was 
divided by the total amount of all non-volatile components which were used for the preparation of the microspheres.            
% Yield = 
    
      
Actual weight of microspheres
Total weight of drug and polymer
 x 100 
2.2.2 Particle size determination: 
Optical microscope was used to determine the size of the microspheres. This method involves the calibration of 
eye piece micrometer for which the stage micrometer is used. In stage micrometer one mm is divided into 100 equal 
divisions and hence, each division is equal to 10 mm and the particles are measured chosen fixed line across the center of 
the particle. The average diameter of was calculated using following formula. Average diameter = Σnd/n×C.F. 
Where n = number of microspheres, d =diameter of microspheres, C.F =calibration factor 
2.2.3 Shape and surface morphology: 
Morphology of microspheres was investigated by using optical Leica microscopy. The photographs of the 
optimized formulations taken by Leica microscope are shown in the figure-6 and figure-7. The results of Leica microscope 
revealed that the microspheres of Rabeprazole sodium using HPMC15000cps combination with carbopol934p as a polymer 
(F5) were spherical and their surface was smooth and devoid of cracks giving them a good appearance. 
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2.2.4 Drug Entrapment efficiency (DEE %): 
The drug Entrapment efficiency of rabeprazole Sodium microspheres was determined by taking accurately 
weighed 100mg of microspheres in a glass mortar and powdered by a glass pastel and treated with 100ml of Phosphate 
buffer of pH 7.4 in a closed volumetric flask and left over night. Then it was transferred into a 250ml beaker and stirred by 
magnetic stirrer using Teflon coated magnetic bead, the temperature was maintained at 37ºC ±0.5ºC. At the end of 1 hour, it 
was centrifuged and supernatant was filtered, the filtrate was analyzed spectrophotometrically at 284nm (Jasco- V-530). 
Dilution was done whenever required using Phosphate buffer pH 7.4, Corresponding drug concentrations in samples was 
calculated from calibration plot. Entrapment efficiency of the microspheres was calculated using the formula. 
DEE % = 
  
  
Practical Drug Loading
Theoretical Drug Loading
 X 100. 
 
Table 2: Percentage yeild ,Mean particle Size ,shape and drug entrapment efficiency of Different Batches of 
Mucoadhesive microspheres of rabeprazole sodium. 
S.No. Formulation code Yield (%) Mean particle size (µm) Shape % Drug entrapment efficiency 
1. F1 87.16 323.12 Oval 71.14 
2. F2 85.29 342.10 Oval 68.12 
3. F3 82.18 427.14 Irregular 64.28 
4. F4 80.37 453.46 Irregular 58.14 
5. F5 92.83 253.26 Round 80.07 
6. F6 90.82 363.86 Oval,round 69.21 
7. F7 89.63 437.78 Oval 66.42 
8. F8 88.59 518.56 Irregular 62.28 
 
2.2.5 Bulk Density: 
A accurately weighed sample of microspheres was carefully introduced into a 10 ml graduated cylinder with the 
aid of funnel. Typically, the initial volume was noted. Carefully level the microspheres without copacting, if necessary, and 
read the unsettled apparent volume V0, to the nearest graduated unit. Calculate the bulk densuty in g/cm
3
 by the formula. 
fD
M

0V
 
Where Df is bulk density, M is weight of samples in grams and V0 is volumes of sample in cm
3
. 
2.2.6 Tapped Density: 
The tapped density was obtained by dividing the mass of a powder by the tapped volume in cm
3
. The sample of 
microspheres is carefully introduced into a 10 ml graduated cylinder. The cylinder was dropped at 2- second intervals onto 
a hard wood surface 100 times from a height of 1 inch. The tapped density of each formulation was then obtained by 
dividing the weight of sample in grams by the final tapped volume in cm
3
 of the sample contained in the cylinder. It was 
calculated by using equation given below 
D
M
o
pV
 
Where Do is bulk density, M is weight of samples in grams and Vp is final tapped volumes of granules in cm
3
. 
 
Table 3: Bulk density of Different Batches of Mucoadhesive microspheres 
S. No. Formulation code Bulk density (gm/cm
3
) Tapped density (gm/cm
3
) 
1. F1 0.277 0.322 
2. F2 0.294 0.344 
3. F3 0.312 0.370 
4. F4 0.322 0.384 
5. F5 0.285 0.322 
6. F6 0.303 0.357 
7. F7 0.344 0.416 
8. F8 0.357 0.434 
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2.2.7 Carr’s Index: 
The compressibility index and the hausner ratio are determined by measuring both bulk volume and tapped volume 
of microspheres. The percentage compressibility of microspheres was calculated according to equation given below. 
% Compressibility Index 0( ) 100
f
f
V V
V
 
Where V0 is bulk density and Vf is Tapped density. 
2.2.8 Hausner ratio: 
Hausner ratio of microspheres was calculated according to equation given below (USP NF 2007). 
Hausner ratio: = 

fV
V
 
where Where V0 is bulk density and Vf is Tapped density. 
2.2.9 Swelling index: 
Preweighed rabeprazole sodium microspheres (W0) formulated with HPMC and Carbopol by employing different 
coat:core ratios were placed in pH 7.4 phosphate buffer which was maintained at 37ºC±0.5ºC. After 6th hour, the 
microcapsules were collected and blotted to remove excess water and weighed (Wt). The swelling index was calculated 
with the following formula. 
 
 100


t 0
0
W W
Swelling index
W
 
Where Wt = weight of microspheres observed at 6th hour; W0 = initial weight of microspheres. 
2.2.10 Mucoadhesion test: 
The mucoadhesive property of microspheres was evaluated by an in-vitro adhesion testing method known as wash-
off method,Freshly excised pieces of goat intestinal mucosa (2 × 2cm
2
) were mounted on to glass slides with cotton thread. 
About 50 microbeads were spread on to each prepared glass slide and immediately thereafter the slides were hung to USP 
tablet disintegration test apparatus, When the test apparatus was operated, the sample is subjected to slow up and down 
movement in the test fluid at 37
0
C±0.5
0
C contained in a 1-liter vessel of the apparatus. At an interval of 1 hours up to 6 
hours the machine is stopped and number of microspheres still adhering to mucosal surface was counted. The test was 
performed at intestinal (Phosphate buffer pH 7.4) condition. 
                                  
% Mucoadhesion =                                                               x 100 
                                     
 
Table 4: Percent compressibility, Hausner ration, Sweeling index and percent mucoadhesion of different Batches of 
Mucoadhesive microspheres. 
S. No. Formulation code 
Compressibility 
index (%) 
Hausner ratio 
Swelling Index 
after 6
th
 hours (%) 
Mucoadhesion 
after 6
th
 hours (%) 
1. F1 13.97 1.16 69% 50 
2. F2 14.53 1.17 85% 54 
3. F3 15.67 1.18 89% 58 
4. F4 16.14 1.19 94% 62 
5. F5 11.49 1.12 73% 74 
6. F6 15.12 1.17 87% 74 
7. F7 17.30 1.20 91% 77 
8. F8 17.74 1.21 97% 79 
 
2.2.11 Differential scanning calorimetry (DSC): 
The physical state of drug, Drug polymer mixture, and formulation was analyzed by DSC. The thermograms of 
Rabeprazole sodium, Rabeprazole sodium microspheres with different polymers were obtained at a scanning rate of 
10°C/min conducted over a temperature range of 25–350ºC, respectively. 
 
Total no. of microspheres remains 
Total no. of applied microspheres   
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2.2.12 In-vitro drug release study: 
The microspheres equivalent to 20 mg of drug Rabeprazole sodium were filled in hard gelatin capsules (no. 4) and 
coated with 1% w/v solution of cellulose acetate phthalate (CAP) by dip-coating method. The coating was accomplished by 
dipping the filled capsules thrice in CAP solution and air drying after each coating step successively. In-vitro drug release 
on the capsules size 4 was undertaken using USP Apparatus 2 at 50 rpm, in 900 ml of medium at 37°C ± 0.5°C with a wire 
sinker. For the enteric capsules 2 h of exposure in 0.1 N hydrochloric acid (pH 1.2) followed by testing in phosphate buffer 
of pH 7.4 for 10 h. A suitable volume of sample were withdrawn of after suitable time interval and equal volume of fresh 
medium was replaced to maintain a constant total volume. Samples were filtered using 0.45μm filter. Rabeprazole sodium 
concentrations were determined by UV spectrophotometry (Jasco- V-530) at a wavelength of 284 nm. 
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3. Result and Discussion 
3.1 Percentage yield: 
Percentage yield of different formulation was determined by weighing the microspheres after drying. It was 
observed that as the polymer ratio in the formulation increases, the product yield slightly decreases. The probable reason 
behind this may be the high viscosity of the solution, adhesion of polymer solution to the wall of beaker and magnetic bead 
which ultimately decreased the production yields of microspheres. The percentage yield was found to be in the range of 
80.33to 92.83%.The percentage yield of different formulation is shown in Table-2. 
Maximum practical yield of around 92.83 % was obtained with batches F5. From other batches like F1, F2, F3, F4, 
F6, F7 and F8 very less practical yield was obtained. 
3.2 Particle size analysis: 
Particle size was determined by Optical microscopy method. It plays important role in mucoadhesive ability and 
release of drug from microspheres. The mean size increased with increasing polymer concentration which is due to a 
significant increase in the viscosity, thus leading to an increased droplet size and finally a large microspheres size. 
Uniform average particle size was obtained for the formulation F5. Microspheres obtained with batch F5 showed 
uniform average particle size of 253.26μm. The average particle size of mucoadhesive microsphere was in range 253.26 – 
518.56 μm as shown in Table -1. 
3.3 Shape and surface morphology: 
Morphology of microspheres was investigated by using optical Leica microscopy.The photographs of the 
optimized formulations taken by Leica microscope are shown in the figure-6 and figure-7. The results of Leica microscope 
revealed that the microspheres of Rabeprazole sodium using HPMC15000cps combination with carbopol934p as a polymer 
(F5) were spherical and their surface was smooth and devoid of cracks giving them a good appearance. 
3.4 Drug Entrapment efficiency (DEE %): 
Drug entrapment efficacy slightly decrease with increase Carbopol content and decreased HPMC ratio in 
microspheres. This is due to the permeation characteristics of Carbopol that could facilitate the diffusion of part of 
entrapped drug to surrounding medium during preparation of microspheres. The % drug entrapment efficacies of different 
formulations were found to be in the range of 58.14 -80.07% w/w. 
3.5 Bulk Density: 
The bulk density of each formulation was determined by dividing the weight of sample in grams by the final 
volume in cm
3
 of the sample contained in the 10 ml graduated cylinder cylinder. The bulk density value of mucoadhesive 
microsphere range from 0.277 to 0.357 gm/cm
3
 as shown in Table No.- 3. Usually, bulk density is of great importance when 
one considers the size of high-dose capsule product or the homogeneity of a low-low-dose formulation in which there are 
large differences in drug and excipient densities. Knowing the anticipated dose and tapped formulation density, one may 
use to determine the appropriate size for a capsule formulation. In a free flowing microspheres such interaction are 
generally less significant, and the bulk and tapped densities will be closer in value. For poor flowing materials, there are 
greater interparticle interactions and a greater bulk and tapped densities will be observed. These differences are reflected in 
compressibility index and hausner ratio . 
3.6 Tapped density: 
Tapped density was determined by tapping method. The tapped density value of different mucoadhesive 
microspheres range from 0.322 to 0.434 gm/cm
3
. 
3.7 Percentage Compressibility index and hausner ratio 
The compressibility index and hausner ratio are measures of the porosity of a microspheres to be compressed as 
such they are measures of the relative interparticulate interaction. In a free flowing microspheres such interaction are 
generally less significant, and the bulk and tapped densities will be closer in value. For poor flowing materials, there are 
greater interparticle interactions and a greater bulk and tapped densities will be observed. These differences are reflected 
incompressibility index and hausner ratio. 
The compressibility index and the closely related hausner ratio have become the simple, fast and popular methods 
of prodicting predicting powder flow characteristics.The compressibility index has been proposed as an indirect methods of 
bulk density. Size shape, sueface area, moisture content, and cohesiveness of materials because all of these can influence 
the observed compressibility index. It is determined by using the value of tapped density and bulk density.The percentage 
compressibility index was found to be range of 11.49 to 17.74% as shown in table 4. The percentage compressibility value 
less than 20 for all formulation. The hausner ratio was found to be range of 1.12 to 1.21 
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3.8 Swelling index: 
Degree of swelling is expressed as the percentage of water in the hydrogel at any instant during swelling. 
Swellability is an important characteristic as it affects mucoadhesion as well as drug release profiles of polymeric drug 
delivery systems. 
The in-vitro swelling property of microspheres was studied in Phosphate buffer pH 7.4. It can be concluded from 
the data that with an increase in polymer concentration, the degree of swelling also increases.Thus we can say that amount 
of polymer directly affects the degree of swelling. As the polymer to drug ratio increased, the degree of swelling increased 
from 69% to 97% for microspheres of Rabeprazole sodium using HPMC and coabopol as copolymer. Swelling index of 
different formulation of rabeprazole sodium mucoadhesive microspheres was determined in pH 7.4 phosphate buffer and its 
range is 69% to 97% as shown in table 4. 
3.9 Mucoadhesion test: 
The mucoadhesive property of microspheres was determined by an in-vitro adhesion testing method known as 
wash-off method. When the Concentration of polymer increases, Mucoadhesion will be increases. High viscosity grade of 
HPMC15000cps with combination of carbopol934p, formulation (F5 to F8) showed highest mucoadhesivity, compare to 
formulation (F1to F4) showed less mucoadhesivity. The percentage of mucoadhesion of different formulation was in range 
of 50-79% as shown in Table-4. 
3.10 Differential scanning calorimetry (DSC) : 
The DSC thermograms of pure drug, physical mixture of drug-polymer and formulation F5 were individually 
generated and investigated for presence of additional peaks or absence of peaks indicating possible polymer interactions or 
phase transformations by instrument DSC-60 (Shimadzu). The thermal peaks give the melting points of the samples which 
can be used as a test for purity analysis and also for sample characterization by comparing with the standard melting points 
reported for corresponding samples. 
DSC of pure drug Rabeprazole sodium peak was observed at 1430C, which corresponds to the melting point of drug. 
Physical mixture of drug and polymer shows endothermic peak at 155.960C, and formulation F5 thermal peaks was 
observed.  
3.11 In-vitro Drug release study: 
In-vitro drug release test were to assure that the micspheres of Rabeprazole sodium are delivered to the target area, 
and to elucidate the release kinetic for the developed formulation. Rabeprazole sodium is unstable at gastric pH and 
therefore the microspheres of the drug were capsulated in hard gelatin capsules, coated with 1% w/v CAP and studied for 
in-vitro release of drug using USP dissolution apparatus 2 in pH 1.2 for 2 h followed by release in pH 7.4. In the initial 2 h, 
Rabeprazole sodium was not released more than 10% in the gastric fluid, thereafter the release was initiated when the pH 
was changed to intestinal fluid (phosphate buffer, pH 7.4) for the next 10 h.The drug release pattern from microspheres of 
Rabeprazole sodium was in a sustained manner, in contrast to the Dissolution of pure drug. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure no.-1 In-vitro drug release for formulation F5. 
However, the release of Rabeprazole sodium from the microspheres made with HPMC15000cps and carbopol934p 
(Formulation F5) percent cumulative drug release (% CDR) was found to be 91.188%. Release data for F5 formulation has 
been shown in Table No.-28. 
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Table 5: Release Kinetic Treatment for Formulation F5 
S.No. Release Kinetic model Correlation coefficient 
1. Zero order model R
2
=0.976 
2. First order model R
2
= 0.954 
3. Higuchi model R
2 
= 0.990 
4. Korsmeyer peppas model R
2  
= 0.844 
 
4. Conclusion 
Drug absorption in the GIT is a highly variable process, prolonging gastric retention of the dosage forms and 
extends the time of drug absorption. Mucoadhesive microspheres are prepared with HPMC and Carbopol successfully by 
the solvent evaporation technique.  
Mucoadhesive microspheres of Rabeprazole sodium showed excellent mucoadhesivity, and prolonged drug release 
up to 12 hours. Microspheres of different size and drug content could be obtained by varying the formulation variables. 
Thus the prepared mucoadhesive microspheres may prove to be potential candidates for oral delivery devices. Formulation  
Batch F5 showed best appropriate balance between mucoadhesivity and drug release rate, which can be considered as a best 
fit for mucoadhesive microspheres. The polymer ratio (HPMC15000cps and Carbopol934p) of 1:1 were selected as best 
formulation, The formulated system showed sustained release up to 12 h and the system is potentially useful to overcome 
poor bioavailability problems associated with Rabeprazole sodium. 
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